evidence indicates that a 12-wk administration of splenda exerted numerous adverse effects, including (1) reduction in beneficial fecal microflora, (2) increased fecal ph, and (3) enhanced expression levels of p-gp, cyp3a4, and cyp2d1, which are known to limit the bioavailability of orally administered drugs.